Product Images Ambrisentan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Ambrisentan NDC 59651-494 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

ambrisentan-fig1.jpg - ambrisentan fig1

ambrisentan-fig1.jpg - ambrisentan fig1

This appears to be a chart showing the interaction of various drugs with ambrisentan, with information on fold change and recommended dosage adjustments. The drugs listed include cyclosporine, mycophenolate moetal, ketoconazole, omeprazole, rifampin, tacrolimus, tadalafil, and warfarin. The chart also includes information on various pharmacokinetic parameters such as Cmax and Auc.*

ambrisentan-fig2.jpg - ambrisentan fig2

ambrisentan-fig2.jpg - ambrisentan fig2

This is a list of drugs that interact with each other along with the recommended dose for each drug. There are no required dose adjustments for any of the drugs on this list. PK and Emax values are also listed.*

ambrisentan-fig3.jpg - ambrisentan fig3

ambrisentan-fig3.jpg - ambrisentan fig3

ambrisentan-fig4.jpg - ambrisentan fig4

ambrisentan-fig4.jpg - ambrisentan fig4

This is a clinical trial study named ARIES that compares the effects of Ambrisentan and Placebo on a group of individuals at different time intervals (ARIES-1 and ARIES-2). The data represents the number of individuals at risk, percentage of individuals with a certain outcome and the time frame measured in weeks. It is not possible to infer further information from this text due to the lack of context and extensive errors.*

Figure 6 - ambrisentan fig5

Figure 6 - ambrisentan fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Container Label (30 Tablets Bottle) - ambrisentan fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mg Container Label (30 Tablets Bottle) - ambrisentan fig6

Ambrisentan Tablets are a prescription drug that contains 5mg of ambrisentan in each film-coated tablet. Pharmacists are advised to provide the medication guide to each patient. The tablet should not be split, crushed, or chewed. The medication should be stored at 20-25°C (68-77°F), but excursions are allowed to 15-30°C. Dispense in the original container and keep it tightly closed. Medication guides can be printed at www.aurobindousa.com/medication-guides. This drug is supplied by Aurobindo Pharma USA, Inc. and is made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg Container Label (30 Tablets Bottle) - ambrisentan fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg Container Label (30 Tablets Bottle) - ambrisentan fig7

Ambrisentan Tablets are prescribed medication that should be dispensed with a Medication Guide provided separately for each patient. Each package contains thirty film-coated tablets, and the usual dosage is ten milligrams per tablet. The tablets should not be split, crushed, or chewed, and must be stored between 20° to 25°C (68° to 77°F), with an permitted excursion of 15° to 30°C (59° to 86°F). The medication should only be dispensed in the original container, and further guidance should be obtained from the package insert. The medication is distributed by Aurobindo Pharma USA, Inc., and further details can be found at www.aurobindousa.com/medication-quides.*

ambrisentan-str.jpg - ambrisentan str

ambrisentan-str.jpg - ambrisentan str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.